Stéphane Bancel, Moderna CEO (AP Photo/Charles Krupa)
August 26, 2022 11:21 AM EDTUpdated 02:59 PM
R&D
Law

Up­dat­ed: Mod­er­na sues Pfiz­er and BioN­Tech for in­fring­ing on mR­NA vac­cine patents used in block­buster Covid shots

Lei Lei Wu

News Reporter

Fol­low­ing its an­nounce­ment in March that it would be­gin en­forc­ing its Covid-19 vac­cine patents in wealthy coun­tries, Mod­er­na says it is su­ing Pfiz­er and BioN­Tech …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

TRENDING NOW

TIG­IT grave­yard ex­pands as GSK drops late-stage as­set with iTeos

Bay­er starts 2025 by cut­ting 2,000 jobs as it homes in on year-end re­haul tar­get

Some gener­ics, biosim­i­lar drug­mak­ers say they can with­stand tar­iff im­pact

Unit­ed­Health Group CEO An­drew Wit­ty steps down

Up­dat­ed: To spin off or not to spin off? Gala­pa­gos backpedals on sep­a­ra­tion plans, CEO Paul Stof­fels ex­its ear­ly

Arc­turus to pri­or­i­tize mR­NA ther­a­peu­tics in bid to boost rare dis­ease pro­grams

A service from the Financial Times